Aventis
French-German company
Written and fact-checked by
The Editors of Encyclopaedia Britannica
Encyclopaedia Britannica's editors oversee subject areas in which they have extensive knowledge, whether from years of experience gained by working on that content or via study for an advanced degree. They write new content and verify and edit content received from contributors.
Updated:
- Date:
- 1999 - present
- Ticker:
- SNY
- Share price:
- $47.13 (mkt close, Apr. 10, 2024)
- Market cap:
- $120.23 bil.
- Annual revenue:
- $46.44 bil.
- Earnings per share (prev. year):
- $4.39
- Sector:
- Life Sciences
- Industry:
- Large Cap Pharma
- CEO:
- Paul Hudson
- Headquarters:
- Strasbourg
Aventis, former French pharmaceutical company founded in 1999 through the merger of the German firm Hoechst and the French company Rhône-Poulenc. With headquarters in Strasbourg, France, Aventis was the product of the first transnational merger to combine large rival companies from France and Germany. It became part of the French pharmaceutical conglomerate Sanofi-Aventis in 2004.